Priya Sachdeva

Stock Analyst at UBS

(2.16)

# 2,845

Out of 5,090 analysts

5

Total ratings

60%

Success rate

6.95%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$330 → $335	$300.66	+11.42%	4	Jul 30, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$16.40	+3.66%	1	Jan 21, 2025

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $300.66

Upside: +11.42%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $16.40

Upside: +3.66%